- Home
- USEG vs MREO Comparison
USEG vs MREO Comparison
Compare USEG & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | USEG | MREO |
|---|---|---|
| Founded | 1966 | 2015 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.5M | 52.5M |
| IPO Year | 1995 | 2017 |
Fundamental Metrics
Financial Performance| Metric | USEG | MREO |
|---|---|---|
| Price | $1.01 | $0.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $3.50 | $1.50 |
| AVG Volume (30 Days) | 1.7M | ★ 3.6M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.21 | 16.67 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $32,379,000.00 | $500,000.00 |
| Revenue This Year | $114,854.51 | $5,184.20 |
| Revenue Next Year | N/A | $55.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.66 | $0.20 |
| 52 Week High | $2.75 | $2.94 |
Technical Indicators
Market Signals| Indicator | USEG | MREO |
|---|---|---|
| Relative Strength Index (RSI) | 56.25 | 65.12 |
| Support Level | $0.94 | $0.33 |
| Resistance Level | $1.08 | $0.36 |
| Average True Range (ATR) | 0.05 | 0.04 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 85.80 | 84.37 |
Price Performance
Historical ComparisonAbout USEG U.S. Energy Corp. (DE)
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).